Over-expression of gene regulator spurs development of leukemia in babies with Down syndrome
By Frontier India Pharmacetuicals News | February 28th, 2010 | Category: Latest, Medical R&D News | No Comments »Between 5 and 10 percent of babies with Down syndrome develop a transient form of leukemia that usually resolves on its own. However, for reasons that haven’t been clear, 20 to 30 percent of these babies progress to a more serious leukemia known as Down syndrome acute megakaryoblastic leukemia (DS-AMKL), which affects the blood progenitor [...]
